Recevez les dernières nouvelles sur l'action Bionano Genomics avec des mises à jour sur les tendances du marché, les données financières et les analyses de Benzinga. Restez informé des performances de BNGO

Dernières nouvelles pour

Bionano Genomics

Aperçu

Actualités

Gains

Orientation

Évaluations des analystes

Transactions internes

Intérêt court

Rapport sur les stocks

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Comments

Bionano Genomics Actualités boursières

Actualités

Dernières nouvelles pour

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL